• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0
×

Target

Host

Species Reactivity

Species Reactivity

Conjugate

Conjugate

CCR3 Polyclonal antibody

CCR3 Polyclonal Antibody for IHC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human and More (1)

Applications

IHC, ELISA

Conjugate

Unconjugated

Cat no : 22351-1-AP

Synonyms

C C chemokine receptor type 3, C C CKR 3, CC CKR 3, CCR 3, CCR3, CD193, CKR3, CMKBR3, Eosinophil eotaxin receptor

Validation Data Gallery

Applications:
  • IHC staining of human tonsillitis using 22351-1-AP

    IHC staining of human tonsillitis using 22351-1-AP

    Immunohistochemical analysis of paraffin-embedded human tonsillitis tissue slide using 22351-1-AP (CCR3 Antibody) at dilution of 1:200 (under 10x lens).

  • IHC staining of human tonsillitis using 22351-1-AP

    IHC staining of human tonsillitis using 22351-1-AP

    Immunohistochemical analysis of paraffin-embedded human tonsillitis tissue slide using 22351-1-AP (CCR3 Antibody) at dilution of 1:200 (under 40x lens).

  • IHC staining of human tonsillitis using 22351-1-AP

    IHC staining of human tonsillitis using 22351-1-AP

    Immunohistochemical analysis of paraffin-embedded human tonsillitis tissue slide using 22351-1-AP (CCR3 Antibody) at dilution of 1:200 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

  • IHC staining of human tonsillitis using 22351-1-AP

    IHC staining of human tonsillitis using 22351-1-AP

    Immunohistochemical analysis of paraffin-embedded human tonsillitis tissue slide using 22351-1-AP (CCR3 Antibody) at dilution of 1:200 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

  • IHC staining of human lymphoma using 22351-1-AP

    IHC staining of human lymphoma using 22351-1-AP

    Immunohistochemical analysis of paraffin-embedded human lymphoma tissue slide using 22351-1-AP (CCR3 Antibody) at dilution of 1:200 (under 10x lens).

  • IHC staining of human lymphoma using 22351-1-AP

    IHC staining of human lymphoma using 22351-1-AP

    Immunohistochemical analysis of paraffin-embedded human lymphoma tissue slide using 22351-1-AP (CCR3 Antibody) at dilution of 1:200 (under 40x lens).

Tested Applications

Positive IHC detected inhuman tonsillitis tissue, human lymphoma tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Immunohistochemistry (IHC)IHC : 1:100-1:400
Sample-dependent, check data in validation data gallery

Published Applications

IHCSee 1 publications below

Product Information

The immunogen of 22351-1-AP is CCR3 Fusion Protein expressed in E. coli.

Tested Reactivity human
Cited Reactivity human, mouse
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen CCR3 fusion protein Ag17926 相同性解析による交差性が予測される生物種
Full Name chemokine (C-C motif) receptor 3
Calculated molecular weight 355 aa, 41 kDa
GenBank accession numberBC110297
Gene symbol CCR3
Gene ID (NCBI) 1232
RRIDAB_2879085
Conjugate Unconjugated
Form Liquid
Purification Method Antigen Affinity purified
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Protocols

Product Specific Protocols
IHC protocol for CCR3 antibody 22351-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
human,mouseIHC

Oncol Rep

SYNPO2 promotes the development of BLCA by upregulating the infiltration of resting mast cells and increasing the resistance to immunotherapy

Authors - Gongjie Ye
View Article